TrueBlue (NYSE:TBI - Get Free Report) is projected to release its earnings data after the market closes on Wednesday, February 19th. Analysts expect TrueBlue to post earnings of ($0.16) per share and revenue of $385.04 million for the quarter. Individual interested in registering for the company's conference call can do so using this link.
TrueBlue Trading Up 1.5 %
NYSE TBI traded up $0.11 during trading hours on Friday, reaching $7.51. 77,356 shares of the company traded hands, compared to its average volume of 111,261. The stock has a market capitalization of $221.94 million, a PE ratio of -1.96, a PEG ratio of 3.66 and a beta of 1.42. TrueBlue has a 12 month low of $6.63 and a 12 month high of $13.08. The company has a 50 day moving average of $7.99 and a two-hundred day moving average of $7.86.
Analysts Set New Price Targets
TBI has been the subject of several research analyst reports. StockNews.com raised TrueBlue from a "sell" rating to a "hold" rating in a report on Friday. BMO Capital Markets lowered their price target on TrueBlue from $11.00 to $10.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th.
Check Out Our Latest Analysis on TrueBlue
About TrueBlue
(
Get Free Report)
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.
Featured Stories
Before you consider TrueBlue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TrueBlue wasn't on the list.
While TrueBlue currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
